|
Originally published In Press as doi:10.1074/jbc.M504868200 on August 11, 2005
J. Biol. Chem., Vol. 280, Issue 41, 34661-34666, October 14, 2005
Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades*
Brian A. Zabel, Supported by National Institutes of Health Training Grant 5 T32 AI07290-15 1,
Samantha J. Allen¶2,
Paulina Kulig||,
Jessica A. Allen ,
Joanna Cichy||3,
Tracy M. Handel¶4, and
Eugene C. Butcher
From the
Laboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, ¶Molecular and Cell Biology, University of California, Berkeley, California 94720, and ||Faculty of Biotechnology, Jagiellonian University, Krakow 30-387, Poland
Proteases function at every level in host defense, from regulating vascular hemostasis and inflammation to mobilizing the "rapid responder" leukocytes of the immune system by regulating the activities of various chemoattractants. Recent studies implicate proteolysis in the activation of a ubiquitous plasma chemoattractant, chemerin, a ligand for the G-protein-coupled receptor CMKLR1 present on plasmacytoid dendritic cells and macrophages. To define the pathophysiologic triggers of chemerin activity, we evaluated the ability of serum- and inflammation-associated proteases to cleave chemerin and stimulate CMKLR1-mediated chemotaxis. We showed that serine proteases factor XIIa and plasmin of the coagulation and fibrinolytic cascades, elastase and cathepsin G released from activated neutrophil granules and mast cell tryptase are all potent activators of chemerin. Activation results from cleavage of the labile carboxyl terminus of the chemoattractant at any of several different sites. Activation of chemerin by the serine protease cascades that trigger rapid defenses in the body may direct CMKLR1-positive plasmacytoid dendritic cell and tissue macrophage recruitment to sterile sites of tissue damage, as well as trafficking to sites of infectious and allergic inflammation.
Received for publication, May 3, 2005
, and in revised form, June 22, 2005.
* This work was supported by National Institutes of Health Grants AI-59635, AI-37832, AI-47822, and GM-37734, Specialized Center of Research Grant HL-67674, Digestive Disease Center Grant DK56339, and a Merit Award from the Veterans Administration (to E. C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
2 Supported by a postdoctoral fellowship from the Cancer Research Institute, New York. Present address: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093
3 Supported by Jagiellonian University grants and a Fulbright fellowship.
4 Supported by grants from the National Institutes of Health (AI37113-09), the University of California Discovery Program (Bio03-10367), and the University of California AIDS Program (1D03-B-005). Present address: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093.
1 To whom correspondence should be addressed: Dept. of Pathology (5234), Stanford University Medical Ctr., Stanford, CA 94305. Tel.: 650-493-5000 (ext. 63132); Fax: 650-858-3986; E-mail: bazabel{at}alum.mit.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Maheshwari, A. R. Kurundkar, S. S. Shaik, D. R. Kelly, Y. Hartman, W. Zhang, R. Dimmitt, S. Saeed, D. A. Randolph, C. Aprahamian, et al.
Epithelial cells in fetal intestine produce chemerin to recruit macrophages
Am J Physiol Gastrointest Liver Physiol,
July 1, 2009;
297(1):
G1 - G10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Albanesi, C. Scarponi, S. Pallotta, R. Daniele, D. Bosisio, S. Madonna, P. Fortugno, S. Gonzalvo-Feo, J.-D. Franssen, M. Parmentier, et al.
Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment
J. Exp. Med.,
January 16, 2009;
206(1):
249 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Y. Du, B. A. Zabel, T. Myles, S. J. Allen, T. M. Handel, P. P. Lee, E. C. Butcher, and L. L. Leung
Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets
J. Biol. Chem.,
January 9, 2009;
284(2):
751 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Guillabert, V. Wittamer, B. Bondue, V. Godot, V. Imbault, M. Parmentier, and D. Communi
Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation
J. Leukoc. Biol.,
December 1, 2008;
84(6):
1530 - 1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Zabel, S. Nakae, L. Zuniga, J.-Y. Kim, T. Ohyama, C. Alt, J. Pan, H. Suto, D. Soler, S. J. Allen, et al.
Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis
J. Exp. Med.,
September 29, 2008;
205(10):
2207 - 2220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yoshimura and J. J. Oppenheim
Chemerin reveals its chimeric nature
J. Exp. Med.,
September 29, 2008;
205(10):
2187 - 2190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Cash, R. Hart, A. Russ, J. P.C. Dixon, W. H. Colledge, J. Doran, A. G. Hendrick, M. B.L. Carlton, and D. R. Greaves
Synthetic chemerin-derived peptides suppress inflammation through ChemR23
J. Exp. Med.,
April 14, 2008;
205(4):
767 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bozaoglu, K. Bolton, J. McMillan, P. Zimmet, J. Jowett, G. Collier, K. Walder, and D. Segal
Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome
Endocrinology,
October 1, 2007;
148(10):
4687 - 4694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Goralski, T. C. McCarthy, E. A. Hanniman, B. A. Zabel, E. C. Butcher, S. D. Parlee, S. Muruganandan, and C. J. Sinal
Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism
J. Biol. Chem.,
September 21, 2007;
282(38):
28175 - 28188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Parolini, A. Santoro, E. Marcenaro, W. Luini, L. Massardi, F. Facchetti, D. Communi, M. Parmentier, A. Majorana, M. Sironi, et al.
The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues
Blood,
May 1, 2007;
109(9):
3625 - 3632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kulig, B. A. Zabel, G. Dubin, S. J. Allen, T. Ohyama, J. Potempa, T. M. Handel, E. C. Butcher, and J. Cichy
Staphylococcus aureus-Derived Staphopain B, a Potent Cysteine Protease Activator of Plasma Chemerin
J. Immunol.,
March 15, 2007;
178(6):
3713 - 3720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kalesnikoff, E. J. Rios, C.-C. Chen, S. Nakae, B. A. Zabel, E. C. Butcher, M. Tsai, S.-Y. Tam, and S. J. Galli
RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
PNAS,
February 21, 2006;
103(8):
2659 - 2664.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|